Besunyen (Beijing Outsell Health)

Besunyen Holdings Company Limited, established in 2000 by co-founders Zhao Yihong and Gao Yan, operates as a prominent supplier of functional health tea and medicines in China. Zhao Yihong, who serves as the Chairman and CEO, leveraged his extensive experience in China's food and beverage industry to pioneer the production and distribution of functional health tea products. His background includes roles at the Jinan Municipal Bureau of Grain and the Ting Hsin International Group. The company achieved a significant milestone with its listing on the main board of the Hong Kong Stock Exchange in September 2010.

The core of Besunyen's business revolves around the research, development, production, and sales of therapeutic tea products and other health-related items, primarily serving the domestic Chinese market. The company's business model is guided by the principle of "One Focus and Two Dimensions," which concentrates on herbal health while expanding into weight management and gastrointestinal health. Revenue is generated through the sale of its products via a vast distribution network. As of late 2023 and early 2024, their offline sales channels included approximately 290,000 to 300,000 pharmacies and terminals across China, complemented by a robust online presence with numerous stores on various e-commerce platforms like Douyin and Kuaishou.

Besunyen's product portfolio is divided into two main segments: Tea Products and Weight-Loss and Other Medicines. The tea segment is famous for its "Two Teas": the Besunyen Detox Tea (Changrun Tea) for improving gastrointestinal function and relieving constipation, and the Besunyen Slimming Tea (Changjing Tea). This line has expanded to include the "Four Teas" with the addition of Fit Tea and Relief Tea. These products are formulated using natural Chinese herbs and tea leaves, based on traditional Chinese medicine principles combined with modern technology. The company holds multiple patents for its tea formulations. Beyond tea, Besunyen has diversified into the over-the-counter (OTC) drug market, notably with its Orlistat weight-loss capsules, and also offers nutritional meal replacements, probiotics, and enzymes. This strategic shift has seen revenue from dietary drugs grow to represent a significant portion of the company's total income.

Keywords: Besunyen, Beijing Outsell Health, functional health tea, therapeutic tea, traditional Chinese medicine, slimming tea, detox tea, weight management, gastrointestinal health, Orlistat, herbal remedies, Chinese health products, Hong Kong Stock Exchange, HK00926, Zhao Yihong, dietary supplements, OTC medicine, laxative tea, health and wellness China, e-commerce health, pharmaceutical sales, nutritional supplements, probiotics, enzyme products